Syren Biotech: 2024 First Extraordinary General Meeting of Shareholders Meeting Information
Syren Biotech: Announcement on holding a briefing on 2024 semi-annual results and cash dividends
Cyron Biotech: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024
Syren Biotech: Board Nomination Committee\'s Review of the Eligibility of Independent Director Candidates for the 4th Board of Directors
Independent Director Nominee\'s Statement and Commitment (Ye Yunping)
Independent Director Nominee\'s Statement and Commitment (Liu Junling)
Independent Director Nominee\'s Statement and Commitment (Fu Yishang)
Independent Director Candidate Statement and Commitment (Ye Yunping)
Independent Director Candidate Statements and Commitments (Liu Junling)
Independent Director Candidate Statement and Commitment (Fu Yishang)
Syren Biotech: Announcement on the election of the Board of Directors and the Board of Supervisors
Fangzheng Securities Underwriting and Sponsorship Co., Ltd. report on the 2024 semi-annual continuous supervision and follow-up report of Shanghai Sailun Biotechnology Co., Ltd.
Syren Biotech: 2024 Semi-Annual Equity Distribution Implementation Notice
Syren Biotech: Announcement on the 2024 Semi-Annual Profit Distribution Plan
Syren Biotech: Special Report on the Storage and Actual Use of Funds Raised for the Semi-Annual Year 2024
Syren Biotech: Semi-Annual Evaluation Report on the 2024 “Improve Quality, Increase Efficiency, and Value Rewards” Action Plan
Syren Biotech: 2024 Semi-Annual Report
Syren Biotech: 2024 Semi-Annual Report Summary
Syren Biotech: Announcement of Resolutions of the 16th Meeting of the 3rd Board of Supervisors
Legal opinion from JinTianCheng Law Firm, Shanghai, regarding the shareholding of one of the actual controlling persons, directors, general managers, and some senior management personnel of Shanghai Cellon Biotechnology Co., Ltd.
No Data
No Data